Time-dependent changes in mortality and transformation risk in MDS

Michael Pfeilstocker (Lead / Corresponding author), Heinz Tuechler, Guillermo Sanz, Julie Schanz, Guillermo Garcia-Manero, Françesc Solé, John M. Bennett, David Bowen, Pierre Fenaux, Francois Dreyfus, Hagop Kantarjian, Andrea Kuendgen, Luca Malcovati, Mario Cazzola, Jaroslav Cermak, Alessandro Levis, Michael Luebbert, Jaroslaw Maciejewski, Sigrid Machherndl-Spandl, Silvia M.M. MagalhaesYasushi Miyazaki, Mikkael A. Sekeres, Wolfgang R. Sperr, Reinhard Stauder, Sudhir Tauro, Peter Valent, Teresa Vallespi, Arjan A. Van De Loosdrecht, Ulrich Germing, Detlef Haase, Peter L. Greenberg

Research output: Contribution to journalArticle

50 Citations (Scopus)
126 Downloads (Pure)

Abstract

In myelodysplastic syndromes (MDS) evolution of risk for disease progression or death has not been systematically investigated despite being crucial for correct interpretation of prognostic risk scores. In a multicenter retrospective study we describe changes in risk over time, the consequences for basal prognostic scores and their potential clinical implications. Major MDS prognostic risk scoring systems (IPSS, IPSS-R, WPSS, LRPSS) and their constituent individual predictors were analyzed in 7,212 primary untreated MDS patients from the IWG-PM database. Changes in risk of mortality and of leukemic transformation over time from diagnosis were described. In higher risk MDS, hazards regarding mortality and AML transformation diminished over time from diagnosis, whereas they remained stable in lower risk patients. After approximately 3.5 years, hazards in the separate risk groups became similar and essentially equivalent after five years. This fact led to loss of prognostic power of different scoring systems considered more pronounced for survival. Inclusion of age resulted in increased initial prognostic power for survival and less attenuation in hazards. If needed for practicability in clinical management the differing development of risks suggested a reasonable division into lower and higher risk MDS based on the IPSS-R at a cut-off of 3.5 points. Our data regarding time-dependent performance of prognostic scores reflect the disparate change of risks in MDS subpopulations. Lower risk patients at diagnosis remain “constant lower risk", while "initially high risk" patients demonstrate decreasing risk over time. This change of risk should be considered in clinical decision making.
Original languageEnglish
Pages (from-to)902-910
Number of pages9
JournalBlood
Volume128
Issue number7
Early online date22 Jun 2016
DOIs
Publication statusPublished - 18 Aug 2016

Fingerprint Dive into the research topics of 'Time-dependent changes in mortality and transformation risk in MDS'. Together they form a unique fingerprint.

  • Cite this

    Pfeilstocker, M., Tuechler, H., Sanz, G., Schanz, J., Garcia-Manero, G., Solé, F., Bennett, J. M., Bowen, D., Fenaux, P., Dreyfus, F., Kantarjian, H., Kuendgen, A., Malcovati, L., Cazzola, M., Cermak, J., Levis, A., Luebbert, M., Maciejewski, J., Machherndl-Spandl, S., ... Greenberg, P. L. (2016). Time-dependent changes in mortality and transformation risk in MDS. Blood, 128(7), 902-910. https://doi.org/10.1182/blood-2016-02-700054